New Member
Posted 06 January 2012 - 01:05 PM
See
Treatment of CML following Imatinib Resistance: A nursing Guide to Second-Line Treatment Options
Stephanie Bauer, MSN, FNP-BC, and Eddie Romvari, MSN, FNP-BC
October 2009, Clinical Oncology Nursing
Other link: http://www.cmleukemi...></span>re.html
Advanced Member
Posted 07 January 2012 - 09:24 AM
The Nursing Guide is very interesting in that it is a readable guide for anyone new to the disease. However, please note that in table 5 the starting dose for Tasigna (nilotinib) is 400 mg. This has been reduced since 2009 to a starting dose of 300 mg. per day.
Pat
Pat
"You can't change the direction of the wind but you can adjust your sails."
DX 12/08; Gleevec 400mg; liver toxicity; Sprycel 100mg.; CCyR 4/10; MMR 8/10; Pleural Effusion 2/12; Sprycel 50mg. Maintaining MMR; 2/15 PCRU; 8/16 drifting in and out of undetected like a wave meeting the shore. Retired 12/23/2016! 18 months of PCRU, most recent at Mayo on 7/25/17 was negative at their new sensitivity reporting of 0.003.<p>
0 members, 1 guests, 0 anonymous users
